boric acid vaginal

Adult Dosing .

Dosage forms:  CAP: 600 mg; SUPP: 600 mg

Special Note

[prescribing info]

Info: not FDA-approved or regulated as a drug

vaginal infection symptoms

[600 mg PV qhs x7-14 days]

Info: for vaginal burning, itching, irritation, dryness, and odor reduction; see product info for specific dosing recommendations

candidiasis, vulvovaginal (off-label)

[treatment]

Dose: 600 mg PV qhs x7-14 days; Info: for non-C. albicans infection; not 1st-line agent

[recurrence]

Dose: 600 mg PV qd x3wk; Info: for non-C. albicans infection; not 1st-line agent

bacterial vaginosis (off-label)

[recurrence]

Dose: 600 mg PV qhs x21 days; Start: after 7 days of oral nitroimidazole tx; Info: not 1st-line agent; follow w/ metronidazole 0.75% gel PV 2x/wk x16wk

renal dosing

[not defined]

renal impairment: not defined

HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Dosage forms:  CAP: 600 mg; SUPP: 600 mg

Special Note

[prescribing info]

Info: not FDA-approved or regulated as a drug

vaginal infection symptoms

[12 yo and older]

Dose: 600 mg PV qhs x7-14 days; Info: for vaginal burning, itching, irritation, dryness, and odor reduction; see product info for specific dosing recommendations

candidiasis, vulvovaginal (off-label)

[treatment, 12 yo and older]

Dose: 600 mg PV qhs x7-14 days; Info: for non-C. albicans infection; not 1st-line agent

[recurrence, 12 yo and older]

Dose: 600 mg PV qd x3wk; Info: for non-C. albicans infection; not 1st-line agent

bacterial vaginosis (off-label)

[recurrence, 12 yo and older]

Dose: 600 mg PV qhs x21 days; Start: after 7 days of oral nitroimidazole tx; Info: not 1st-line agent; follow w/ metronidazole 0.75% gel PV 2x/wk x16wk

renal dosing

[not defined]

renal impairment: not defined

HD/PD: not defined

hepatic dosing

[not defined]